Binge Drug Use Independently Predicts HIV Seroconversion Among Injection Drug Users: Implications for Public Health Strategies

References

• Archibald C. P., Ofner M., Strathdee S. A. Factors associated with frequent needle exchange program attendance in injection drug users in Vancouver, Canada. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1998; 17(2)160–166, [CSA]
   PubMedGoogle Scholar
• Battjes R. J., Pickens R. W., Haverkos H. W. HIV risk factors among injecting drug users in five US cities. AIDS 1994; 8(5)681–687, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Bluthenthal R. N., Kral A. H., Erringer E. A. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995. Journal of Acquired Immune Deficiency Syndromes & Human Retrovirology 1998; 18(5)505–511, [CSA]
   PubMedGoogle Scholar
• Chaisson R. E., Bacchetti P., Osmond D. Cocaine use and HIV infection in intravenous drug users in San Francisco.[comment]. Journal of American Medical Association 1989; 261(4)561–565, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Craib K. J., Spittal P. M., Wood E. Risk factors for elevated HIV incidence among Aboriginal injection drug users in Vancouver [comment]. CMAJ Canadian Medical Association Journal 2003; 168(1)19–24, [CSA]
   PubMed Web of Science ®Google Scholar
• De Irala J., Bigelow C., McCusker J. Reliability of self-reported human immunodeficiency virus risk behaviors in a residential drug treatment population. American Journal of Epidemiology 1996; 143(7)725–732, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• de Vos J. W., Ufkes J. G., van Brussel G. H. Craving despite extremely high methadone dosage. Drug & Alcohol Dependence 1996; 40(3)181–184, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Des Jarlais D. C., Marmor M., Paone D. HIV incidence among injecting drug users in New York City syringe-exchange programmes. Lancet 1996; 348(9033)987–991, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Diggle P., Liang K., Zeger S. Analysis of Longitudinal Data. Oxford University Press, Cambridge 1996
   Google Scholar
• Dolan K. A., Wodak A. HIV transmission in a prison system in an Australian State. [comment]. Medical Journal of Australia 1999; 171(1)14–17, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Drucker E., Lurie P., Wodak A. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV. AIDS 1998; 12: S217–S230, Suppl. A[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   Web of Science ®Google Scholar
• Estebanez P. E., Russell N. K., Aguilar M. D. Women, drugs and HIV/AIDS: results of a multicentre European study. International Journal of Epidemiology 2000; 29(4)734–743, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Fischer B., Rehm J., Kirst M. Heroin-assisted treatment as a response to the public health problem of opiate dependence. [comment]. European Journal of Public Health 2002; 12(3)228–234, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Fuller C. M., Vlahov D., Latkin C. A. Social circumstances of initiation of injection drug use and early shooting gallery attendance: implications for HIV intervention among adolescent and young adult injection drug users. Journal of Acquired Immune Deficiency Syndromes: JAIDS 2003; 32(1)86–93, [CSA]
   PubMed Web of Science ®Google Scholar
• Guadagnino V., Zimatore G., Izzi A. Relevance of intravenous cocaine use in relation to prevalence of HIV, hepatitis B and C virus markers among intravenous drug abusers in southern Italy. Journal of Clinical & Laboratory Immunology 1995; 47(1)1–9, [CSA]
   PubMedGoogle Scholar
• Hagan H., Jarlais D. C., Friedman S. R. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program. [comment]. American Journal of Public Health 1995; 85(11)1531–1537, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar
• Kerr T., Wood E., Small D. Potential use of safer injection facilities among injection drug users in Vancouver's Downtown Eastside. CMAJ 2003; 169(8), Oct 14, 2003[CSA]
   PubMedGoogle Scholar
• Lamothe F., Bruneau J., Soto J. Increasing prevalence of HIV-1 infection among injection drug users in Montréal. Canadian Communicable Disease Report 1992; 18: 98–101, [CSA]
   PubMedGoogle Scholar
• McLellan A., Arndt I., Metzger D. The effects of psychosocial services in substance abuse treatment. Journal of American Medical Association 1993; 269: 1953–1959, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Miller C. L., Johnston C., Spittal P. M. Opportunities for prevention: hepatitis C prevalence and incidence in a cohort of young injection drug users. Hepatology 2002; 36(3)737–742, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Perneger T. V., Giner F., del Rio M. Randomised trial of heroin maintenance programme for addicts who fail in conventional drug treatments. BMJ 1998; 317(7150)13–18, [PUBMED], [INFOTRIEVE], [CSA]
   PubMedGoogle Scholar
• Rothon D. A., Mathias R. G., Schechter M. T. Prevalence of HIV infection in provincial prisons in British Columbia. [comment]. CMAJ Canadian Medical Association Journal 1994; 151(6)781–787, [CSA]
   PubMed Web of Science ®Google Scholar
• Spittal P., Small W., Wood E. How otherwise dedicated AIDS prevention workers come to support state-sponsored shortage of clean syringes in Vancouver, Canada. International Journal of Drug Policy. 2003a, In press[CSA]
   Google Scholar
• Spittal P. M., Bruneau J., Craib K. J. Surviving the sex trade: a comparison of HIV risk behaviors among street-involved women in two Canadian cities who inject drugs. AIDS Care 2003b; 15(2)187–195, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Spittal P. M., Craib K. J., Wood E. Risk factors for elevated HIV incidence rates among female injection drug users in Vancouver. CMAJ Canadian Medical Association Journal 2002; 166(7)894–899, [CSA]
   PubMed Web of Science ®Google Scholar
• Strathdee S. A., Patrick D. M., Archibald C. P. Social determinants predict needle-sharing behavior among injection drug users in Vancouver, Canada. Addiction 1997a; 92(10)1339–1347, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Strathdee S. A., Patrick D. M., Currie S. L. Needle exchange is not enough: lessons from the Vancouver injecting drug use study. AIDS 1997b; 11(8)F59–F65, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Tyndall M. W., Currie S., Spittal P. Intensive injection cocaine use as the primary risk factor in the Vancouver HIV-1 epidemic.[comment]. AIDS 2003; 17(6)887–893, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• van d en, Brink W., Hendriks V. M., Blanken P. Medical prescription of heroin to treatment resistant heroin addicts: two randomised controlled trials. BMJ 2003; 327(7410)310, [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Vlahov D., Des Jarlais D. C., Goosby E. Needle exchange programs for the prevention of human immunodeficiency virus infection: epidemiology and policy. American Journal of Epidemiology 2001; 154: S70–S77, Suppl. 12[PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMedGoogle Scholar
• Watters J. K., Estilo M. J., Clark G. L. Syringe and needle exchange as HIV/AIDS prevention for injection drug users. [comment]. Journal of American Medical Association 1994; 271(2)115–120, [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Wood E., Kerr T., Spittal P. M. The potential public health and community impacts of safer injecting facilities: evidence from a cohort of injection drug users. Journal of Acquired Immune Deficiency Syndromes: JAIDS 2003a; 32(1)2–8, [CSA]
   PubMed Web of Science ®Google Scholar
• Wood E., Small W., Spittal P. Do unsafe injection practices explain the association between HIV infection and incarceration among injection drug users?. Journal of Infectious Disease 2003b, In press[CSA]
   Google Scholar
• Wood E., Tyndall M. W., Spittal P. M. Factors associated with persistent high-risk syringe sharing in the presence of an established needle exchange programme. AIDS 2002; 16(6)941–943, [PUBMED], [INFOTRIEVE], [CROSSREF], [CSA]
   PubMed Web of Science ®Google Scholar
• Zaric G., Barnett P., Brandeau M. HIV transmission and the cost-effectiveness of methadone maintenance. American Journal of Public Health 2000; 90: 1100–1111, [PUBMED], [INFOTRIEVE], [CSA]
   PubMed Web of Science ®Google Scholar